Data protection Impressum

Radiotherapy

EBAMed has secured an additional EUR 1.6 million in Series A funding, bringing the total raised to EUR 16 million. This new investment, contributed by CDP Venture Capital and the European Union, supports the development of EBAMed’s groundbreaking CardioKit system for non-invasive treatment of heart arrhythmias using Proton Therapy.

Geneva medtech EBAMed completes financing round with EUR 16 million

27 January 2025

Tau imaging with 18F-Flortaucipir PET in Alzheimer’s disease. The figure shows a prototypical tau accumulation pattern, obtained by comparing tau load of patients with Alzheimer’s disease vs healthy controls. The blue-to-white color scale indicates more pronounced tau loads, with pink-white areas representing those with the highest accumulation.

HUG and UNIGE unveil the next frontier in Alzheimer’s diagnosis

15 August 2023

Biopôle-based digital health specialist Incepto raises EUR 27 million

22 September 2022

CERN and Lausanne University Hospital collaborate on a pioneering new cancer radiotherapy facility

16 September 2020